The MarketReader Minute
The trade development could benefit the healthcare sector, which IBB is heavily invested in, the ETF's performance is still negative. Among its holdings, notable contributors to the decline include AMGN, VRTX, MRNA, GILD, and MTD, all posting losses.
The MarketReader Minute
(IBB) has experienced a decline of 1.7% during market hours on Tuesday. The ETF's top holdings have also contributed to its decline, with significant losses reported from companies such as HALO and REGN.
The MarketReader Minute
Within the ETF's holdings, significant declines were noted for several companies: Vertex Pharmaceuticals (VRTX) dropped, while Sarepta Therapeutics (SRPT) fell sharply.
The MarketReader Minute
(IBB) has seen a decline of 2.6% during Tuesday's trading session. Among the ETF's holdings, significant contributors to its performance included Vertex Pharmaceuticals, Regeneron, Amgen, Moderna, and Gilead Sciences, all of which experienced notable declines in their stock prices.
The MarketReader Minute
Among the ETF's holdings, significant contributors include REGN, VRTX, MTD, MRNA, and GILD, all showing positive returns. Additionally, the Russell 2000 Index has increased by 1.17%, reflecting broader market sentiment that often impacts the biotechnology sector.
The MarketReader Minute
Among the ETF's holdings, Moderna reported a significant drop in first-quarter revenues, contributing negatively to IBB's performance. Regeneron Pharmaceuticals is set to present new oncology data at the 2025 ASCO Annual Meeting, coinciding with a lowered price target from Guggenheim.
The MarketReader Minute
(IBB) has seen a price movement of -0.3% since Friday. In terms of performance among holdings, significant contributors included MRNA, BIIB, NBIX, BPMC, and INSM, all of which posted negative returns.
The MarketReader Minute
(IBB) has experienced a decline of 2.5% during Monday's trading session, coinciding with significant downturns in the broader U.S. stock market. Major indices are falling sharply due to concerns over President Trump's upcoming reciprocal tariffs, which are expected to take effect on April 2nd.
The MarketReader Minute
Bank of Canada announced a reduction in its target overnight rate by 25 basis points due to heightened trade tensions from new U.S. tariffs, influencing market sentiment regarding economic stability, which may negatively impact healthcare equities like the iShares Biotechnology ETF (IBB).
The MarketReader Minute
Key holdings within IBB have also faced losses, including Vertex Pharmaceuticals and Moderna, both of which contributed negatively to the ETF's performance.
The MarketReader Minute
Among the ETF's holdings, BioNTech SE reported a net profit for Q4 2024 that was lower than the previous year, alongside total revenue that fell short of prior estimates
The MarketReader Minute
(IBB) has seen a price movement of -0.5% since Friday. Among the ETF's holdings, Fortrea Holdings reported fourth-quarter financials that fell short of expectations, contributing to negative performance from several key stocks.
